Aspen Pharmacare targets earnings lift from weight-loss drug rollout
Aspen Pharmacare said the rollout of its weight-loss drugs will help drive a 17% rise in next year’s earnings. In South Africa, it sells Mounjaro and plans to begin offering its own generic drug.